Page last updated: 2024-08-26

lysophosphatidic acid and biphenylylacetic acid

lysophosphatidic acid has been researched along with biphenylylacetic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, H; Jun, HS; Kim, D; Lee, JH; Sarker, MK; Shin, D	1

Other Studies

1 other study(ies) available for lysophosphatidic acid and biphenylylacetic acid

Article	Year
Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase. Biochimica et biophysica acta. Molecular basis of disease, 2019, 06-01, Volume: 1865, Issue:6 Topics: Albuminuria; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hypoglycemic Agents; JNK Mitogen-Activated Protein Kinases; Kidney Glomerulus; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidative Stress; Phenylacetates; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; RNA, Small Interfering; Signal Transduction; Streptozocin; Toll-Like Receptor 4; Transcription Factor RelA	2019

Article

Year

Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.

Biochimica et biophysica acta. Molecular basis of disease, 2019, 06-01, Volume: 1865, Issue:6

Topics: Albuminuria; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Hypoglycemic Agents; JNK Mitogen-Activated Protein Kinases; Kidney Glomerulus; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidative Stress; Phenylacetates; Reactive Oxygen Species; Receptors, Lysophosphatidic Acid; RNA, Small Interfering; Signal Transduction; Streptozocin; Toll-Like Receptor 4; Transcription Factor RelA

2019